Alphatec (NASDAQ:ATEC) EVP Sells $549,536.18 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Craig Hunsaker sold 37,358 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $14.71, for a total value of $549,536.18. Following the sale, the executive vice president owned 1,173,025 shares of the company’s stock, valued at $17,255,197.75. The trade was a 3.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Alphatec Trading Up 2.4%

Shares of ATEC stock opened at $13.82 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.99 and a debt-to-equity ratio of 43.02. Alphatec Holdings, Inc. has a fifty-two week low of $8.81 and a fifty-two week high of $23.29. The firm’s 50 day moving average price is $18.85 and its two-hundred day moving average price is $17.01. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of -13.29 and a beta of 1.01.

Analyst Ratings Changes

ATEC has been the subject of several analyst reports. Loop Capital set a $25.00 target price on Alphatec in a research report on Wednesday, December 10th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Alphatec in a report on Monday, December 29th. Needham & Company LLC reaffirmed a “buy” rating and set a $22.00 price target on shares of Alphatec in a research note on Monday, January 12th. Wall Street Zen upgraded shares of Alphatec from a “hold” rating to a “buy” rating in a report on Saturday, January 31st. Finally, TD Cowen restated a “buy” rating on shares of Alphatec in a research note on Tuesday, January 27th. Ten equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $22.82.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Aster Capital Management DIFC Ltd acquired a new stake in shares of Alphatec in the 3rd quarter valued at about $34,000. Osterweis Capital Management Inc. acquired a new position in Alphatec in the second quarter worth about $37,000. China Universal Asset Management Co. Ltd. bought a new stake in Alphatec in the third quarter valued at about $73,000. FNY Investment Advisers LLC acquired a new stake in Alphatec during the third quarter valued at approximately $74,000. Finally, Nisa Investment Advisors LLC lifted its holdings in Alphatec by 22.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 5,714 shares of the medical technology company’s stock worth $63,000 after buying an additional 1,045 shares during the last quarter. 66.35% of the stock is owned by institutional investors and hedge funds.

About Alphatec

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.